Label: DR. THROWERS SPF 30 FACE AND BODY SUNSCREEN- avobenzone 3%, homosalate 12%, octisalate 5%, octocrylene 3% lotion
- NDC Code(s): 72839-605-02
- Packager: Derma Care Research Labs, LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated January 26, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purpose
- Uses
- Warnings
- Keep Out of Reach of Children.
-
Directions
Apply liberally 15 minutes before sun exposure. Reapply:
- after 80 minutes of swimming or sweating
- immediately after towel drying
- at least every 2 hours
Sun protection measures: spending time n the sun increases your risk of skin cancer and early skin aging. To decrease risk, regularly use a sunscreen with broad spectrum SPF of 15 or higher and other sun protection measure including:
- limit time in the sun, especially from 10 am to 2 pm
- wear long-sleeved shirts, pants, hats, and sunglasses.
- Children under 6 months: ask a doctor.
-
Inactive Ingredients
Water, Cetyl Dimethicone, C12-15 Alkyl Benzoate, Hydrated Silica, Styrene/Acrylates Copolymer, Neopentyl Glycol Diheptanoate, Polyester-7, Capryloyl Glycine, Polyester-8, Cinnamomum Zeylanicum Bark Extract, Portulaca Oleracea Extract, Propylene Glycol, Acrylates/Dimethicone Copolymer, BHT, Bisabolol, Caprylyl Glycol, Cedrus Atlantica Bark Extract, Chlorphenesin, Cyclopentasiloxane, Disodium EDTA, Ethylhexyl Stearate, Ethylhexylglycerin, Mannan, Sarcosine, Sodium Polyacrylate, Steareth-2, Steareth-100, Trideceth-6, Xanthan Gum, Phenoxyethanol.
- Label
-
INGREDIENTS AND APPEARANCE
DR. THROWERS SPF 30 FACE AND BODY SUNSCREEN
avobenzone 3%, homosalate 12%, octisalate 5%, octocrylene 3% lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72839-605 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 5 g in 100 g AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 3 g in 100 g OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 3 g in 100 g HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 12 g in 100 g Inactive Ingredients Ingredient Name Strength CAPRYLYL GLYCOL (UNII: 00YIU5438U) STEARETH-100 (UNII: 4OH5W9UM87) PURSLANE (UNII: M6S840WXG5) EDETATE DISODIUM (UNII: 7FLD91C86K) CINNAMON BARK OIL (UNII: XE54U569EC) POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED) (UNII: T9296U138P) CETYL DIMETHICONE 25 (UNII: U4AS1BW4ZB) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) HYDRATED SILICA (UNII: Y6O7T4G8P9) BUTYL METHACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID/STYRENE CROSSPOLYMER (UNII: V5RS026Q0H) NEOPENTYL GLYCOL DIHEPTANOATE (UNII: 5LKW3C543X) POLYESTER-7 (UNII: 0841698D2F) CAPRYLOYL GLYCINE (UNII: 8TY5YO42NJ) WATER (UNII: 059QF0KO0R) LEVOMENOL (UNII: 24WE03BX2T) PPG-1 TRIDECETH-6 (UNII: 1K7417JX6Q) XANTHAN GUM (UNII: TTV12P4NEE) 2-ETHYLHEXYL ACRYLATE, METHACRYLATE, METHYL METHACRYLATE, OR BUTYL METHACRYLATE/HYDROXYPROPYL DIMETHICONE COPOLYMER (30000-300000 MW) (UNII: S7ZA3CCJ4M) CHLORPHENESIN (UNII: I670DAL4SZ) SARCOSINE (UNII: Z711V88R5F) CEDRUS ATLANTICA BARK (UNII: ITP1Q41UPF) STEARETH-2 (UNII: V56DFE46J5) PHENOXYETHANOL (UNII: HIE492ZZ3T) SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L) YEAST MANNAN (UNII: 91R887N59P) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) CYCLOMETHICONE 5 (UNII: 0THT5PCI0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72839-605-02 57 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 09/28/2021 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part352 09/28/2021 Labeler - Derma Care Research Labs, LLC (116817470)
